Skip to content

Towards patient-led follow-up after curative treatment of stage II and III colorectal cancer

Towards patient-led follow-up after curative treatment of stage II and III colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20781
Enrollment
360
Registered
2021-01-11
Start date
2022-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

A patient-led home-based follow-up plan for curatively treated stage II/III CRC patients, starting 12 months after surgery.

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: - Patient has pT2-4N0M0 or pT1-4N1-2M0 primary colorectal carcinoma treated with surgical resection with curative intent; - Patient is aged = 18 years; - Patient is willing to participate in the Prospective Dutch CRC cohort (PLCRC); - Patient is disease-free at 12 months after resection (assessed by CT thorax19 abdomen, CEA and colonoscopy).

Exclusion criteria

Exclusion criteria: - Patient has macroscopically (R2) incomplete resections; - Patient needs in-hospital follow-up longer than 12 months postoperatively (e.g. patients with a severely complicated postoperative course, or patients enrolled in other studies that require in-hospital follow-up consultations); - Patient has confirmed hereditary CRC

Design outcomes

Primary

MeasureTime frame
Primary endpoint is the proportion of participant who have contacted the hospital between 12 and 24 months after curative surgery.

Secondary

MeasureTime frame
Secondary endpoints are quality of life, fear of cancer recurrence, patient satisfaction, cost-effectiveness and survival.

Contacts

Public ContactH. Swartjes

Radboud University Medical Center

hidde.swartjes@radboudumc.nl-

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)